News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19

Publish date: December 22, 2021

 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
MDedge Family Medicine
Axilla swelling after COVID booster puts focus on mammogram timing
MDedge Family Medicine
COVID-19 and coping with superimposed traumas
MDedge Family Medicine
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
MDedge Family Medicine
RSV resurgence likely in wake of COVID-19
MDedge Family Medicine
Children and COVID: New cases up slightly, vaccinations continue to slow
MDedge Family Medicine
Bamlanivimab’s effects in COVID-19 depend on antibodies
MDedge Family Medicine
Convalescent plasma cuts COVID-19 hospitalizations in half: Study
MDedge Family Medicine
GI symptoms in kids with COVID may predict severe outcomes
MDedge Family Medicine
Pandemic poses short- and long-term risks to babies, especially boys
MDedge Family Medicine